Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) by Porpiglia, Francesco et al.
This full text was downloaded from iris - AperTO: https://iris.unito.it/
iris - AperTO
University of Turin’s Institutional Research Information System and Open Access Institutional Repository
This Accepted Author Manuscript (AAM) is copyrighted and published by Elsevier. It is
posted here by agreement between Elsevier and the University of Turin. Changes resulting
from the publishing process - such as editing, corrections, structural formatting, and other
quality control mechanisms - may not be reflected in this version of the text. The definitive
version of the text was subsequently published in UROLOGY, 89 (1), 2016,
10.1016/j.urology.2015.08.049.
You may download, copy and otherwise use the AAM for non-commercial purposes
provided that your license is limited by the following restrictions:
(1) You may use this AAM for non-commercial purposes only under the terms of the
CC-BY-NC-ND license.
(2) The integrity of the work and identification of the author, copyright owner, and
publisher must be preserved in any copy.
(3) You must attribute this AAM in the following format: Creative Commons BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/deed.en),
10.1016/j.urology.2015.08.049
The publisher's version is available at:
http://linkinghub.elsevier.com/retrieve/pii/S0090429515011449
When citing, please refer to the published version.
Link to this full text:
http://hdl.handle.net/
Partial Nephrectomy in Clinical T1b Renal 
Tumors: Multicenter Comparative Study of 
Open, Laparoscopic and Robot-assisted 
Approach (the RECORd Project)  
Francesco Porpiglia
a
, Andrea Mari
b
, Riccardo Bertolo
a
, Alessandro Antonelli
c
, Giampaolo Bianchi
d
, 
Francesco Fidanza
d
,  Cristian Fiori
a
,  Maria Furlan
c
,  Giuseppe Morgia
e
,  Giacomo Novara
f
,  
Bernardo Rocco
g
,  Bruno Rovereto
h
,  Sergio Serni
b
,  Claudio Simeone
c
,  Marco Carini
b
,  Andrea 
Minervini
b, ,  
 
Objective 
To evaluate perioperative results of open (OPN), laparoscopic (LPN), and robot-assisted partial 
nephrectomies (RAPN) and to identify predictive factors of Trifecta achievement for clinical T1b 
renal tumors in a multicenter prospective dataset. 
Methods 
Data of 285 patients who had OPN (133), LPN (57), or RAPN (95) for cT1b renal tumors were 
extracted from the RECORd Project. High-volume centers were defined as ≥50 overall cases of 
partial nephrectomy per year. Trifecta was defined as simultaneous absence of perioperative 
complications, negative surgical margins, and ischemia time <25 minutes. 
Results 
The 3 groups had comparable body mass index, preoperative hemoglobin, creatinine and estimated 
glomerular filtration rate, tumor clinical diameter, and growth pattern. LPN and RAPN were more 
frequently exclusive of high-volume centers. RAPN showed significantly lower median estimated 
blood loss compared with OPN and LPN. Trifecta was achieved in 62.4%, 63.2%, and 69.5% of 
OPN, LPN, and RAPN (P = NS) cases. Median warm ischemia time (WIT) was significantly 
shorter during OPN than during LPN and RAPN. RAPN had significantly shorter WIT compared 
with LPN. RAPN was significantly less morbid than OPN regarding intraoperative and 
postoperative complications. LPN (1.9%) and RAPN (2.5%) showed a lower rate of positive 
margins compared with OPN (6.8%) (P =  NS). At multivariable analysis, exophytic tumor growth 
pattern, estimated blood loss, and high-volume centers were significant predictive factors for 
Trifecta achievement. 
Conclusion 
Clinically, T1b renal tumors suitable for NSS can be safely treated by LPN or RAPN in high-
volume centers. RAPN allows for significantly lower WIT and estimated blood loss with higher rate 
of Trifecta achievement compared with LPN. 
Partial nephrectomy (PN) is nowadays strongly recommended by international guidelines when 
considering surgical treatment of small renal masses cT1 staged.
1 and 2
 Goals of PN are negative 
cancer margin, minimal renal functional decrease, and avoidance of complications. In latest years, 
these goals are together constituting “Trifecta”, a concept taken from radical prostatectomy's 
literature now introduced in surgery for renal cancer to standardize reporting of PN outcomes. 
Trifecta is achieved when warm ischemia time (WIT) less than 25 minutes, negative surgical 
margins, and no perioperative complications are simultaneously realized.
3, 4 and 5
 For many years, 
open PN (OPN) has been considered the “gold standard” but since advancements in laparoscopic 
techniques, equipment, and operator skills, laparoscopy has been becoming more and more 
commonly used,
2
 as offering comparable oncological outcomes, less morbidity, and shortened 
convalescence.
2, 6, 7, 8 and 9
 As such, for clinical T1a lesions, surgical removal choosing a minimally 
invasive approach is nowadays well established. 
In patients with larger renal masses, the role of PN is less well established. In fact, European 
Association of Urology Guidelines support routine use of nephron sparing surgery (NSS) also for 
T1b tumors as it affords conservation of normal renal parenchyma, even preserving oncologic 
efficacy. Conversely, American Urological Association Guidelines support radical nephrectomy as 
standard of care in patients with major comorbidity or high surgical risk and suggest NSS as an 
alternative standard of care only in healthy patients, particularly when there is a need to preserve 
renal function.
1 and 2
 Several recent population reviews together with smaller single or multi-
institutional studies have showed that the cancer-specific survival is similar in patients undergoing 
partial or radical nephrectomy for T1b lesions.
6, 7, 8, 10, 11 and 12
 Moreover, NSS for renal masses 
greater than 4 cm seems to be able to provide additional functional benefits and lower incidence of 
cardiovascular morbidities in the long-term period.
13
 
In these larger lesions, the use of a minimally invasive approach is less adopted. Indeed, 
laparoscopic PN (LPN) is a technically challenging procedure and it is still often confined in the 
hand of a few expert surgeons in tertiary centers. In recent years, the widespread diffusion of 
robotic system has bridged the technical difficulties of LPN leading to a broader choice of 
minimally invasive approach to larger renal masses by robot-assisted PN (RAPN).
14, 15 and 16
 
To date, no study has compared the perioperative outcome of T1b renal tumors after the 3 currently 
available surgical options, namely, OPN, LPN, and RAPN. With this purpose, we designed the 
present multicenter comparative study. Analysis was specifically aimed to intraoperative and 
perioperative data. The secondary aim of the study was to perform a univariate and multivariable 
analysis looking for predictive factors of Trifecta achievement. 
Methods 
Data of 285 patients who had RAPN, LPN, and OPN for cT1b renal tumors were extracted from the 
Registry of Conservative Renal Surgery database (RECORd Project, 19 Italian centers, January 
2009-December 2012) promoted by the “Leading Urological No Profit Foundation Advanced 
Research” (LUNA) of the Italian Society of Urology17 and from the preliminary data (January 
2013-December 2013) of three high-volume centers, participating in the ongoing RECORd2 project 
(Florence, Careggi Hospital; Brescia, AO Spedali Civili; Orbassano [Turin] San Giovanni Gonzaga 
Hospital). High-volume centers were defined as ≥50 overall cases of PN per year. Surgeons were all 
skilled in performing either RAPN, LPN, or OPN. Clinical staging included abdominal computed 
tomography (CT) and chest CT or X-rays. Magnetic resonance imaging was used in a few patients 
as an alternative to CT. Bone scans and brain CT were obtained only when indicated by the signs 
and symptoms. Open procedures were performed using mainly a flank retroperitoneal approach. 
Tumor excision was done by clamping the renal pedicle or with no clamping, using manual 
compression of the surrounding renal parenchyma. Opened calyces and bleeding sites were sutured 
and the parenchymal defect was closed with horizontal interrupted sutures with or without the 
application of hemostatic agents (FloSeal, Baxter Healthcare; Tachosil, Nycomed; Tabotamp, 
Ethicon). Minimally invasive laparoscopic and robotic procedures were performed using either a 
transperitoneal or a retroperitoneal approach according to surgeon's and center's preferences. Tumor 
excision was done by warm ischemia or with a clampless procedure. An early unclamping after 
parenchymal sutures on the tumor bed was adopted when indicated. The parenchymal defect was 
repaired using the sliding-clip technique. Hemostatic agents were used in most cases before cortical 
closure. 
Data Collection 
All the variables recorded were prospectively collected in an online controlled database. Estimated 
glomerular filtration rate (eGFR) was calculated with the Modification of Diet in Renal Disease 
equation.
18
 As pathological variables, tumor nodes metastasis cancer staging system was assigned 
according to the 2009 version,
19
 histological subtypes according to the World Health Organization 
classification,
20
 and nuclear grade according to the Fuhrman grading system.
21
 A positive surgical 
margin was defined as the presence of cancer cells at the level of the inked parenchymal excision 
surface. No central pathological slide review was provided. The pathological features were assigned 
by the uropathologists of each participating center. 
The complications up to 3 months after surgery were classified according to the Dindo modification 
of the Clavien system and to the European Association of Urology standardized quality criteria on 
reporting PN surgical complications.
22 and 23
 Trifecta outcome was defined as simultaneous 
achievement of WIT <25 min, absence of complications, and negative surgical margin as suggested 
by Khalifeh et al.
3
 
The hemoglobin and eGFR at 1 and 3 days after surgery were collected and the differences between 
preoperative and postoperative values were calculated. 
Statistical Analyses 
Continuous parametric variables were reported as the mean ± standard deviation (SD), whereas 
nonparametric variables were reported as the median and interquartile range (IQR). The Mann-
Whitney U-test and unpaired Student's t-test were used to compare continuous variables, as 
appropriate. Categorical variables are reported as frequencies and proportions. Pearson's chi-square 
test was used to compare categorical variables. A univariate and multivariable logistic regression 
was performed for Trifecta outcome. For all statistical analyses, a two-sided P <.05 was considered 
statistically significant. Analyses were performed using SPSS version 20.0 (SPSS Inc., Chicago, 
IL). 
Results 
Overall, 133 OPN, 57 LPN, and 95 RAPN were analyzed. Preoperative data are reported in Table 1. 
Median (IQR) clinical tumor diameter was 5.0 (4.3-5.5) cm and 63% of tumors were mainly 
exophytic. The 3 groups had comparable body mass index, preoperative hemoglobin, creatinine, 
eGFR, tumor clinical diameter, and tumor growth pattern (Table 2). Females were more represented 
in RAPN group (55.8%) compared with LPN group (26.3%; P = .01) ( Table 2). Patients 
undergoing RAPN were significantly younger (mean age of 57.3 years; SD 15.1 years) compared 
with patients in OPN group (mean age of 62.3 years; SD 13.8 years; P = .01) ( Table 2). Tumors in 
the LPN group showed a significantly higher mesorenal location (40.4%) compared with those of 
OPN group (24.8%; P = .03) ( Table 2). 
Table 1.  
Overall preoperative data 
Preoperative data (n = 285) 
 
Gender, n (%) 
Male 171 60.0% 
Female 114 40.0% 
Age, mean SD 60.3 14.3 
BMI, median IQR 25.9 23.1-28.4 
ECOG, n (%) 
0 219 76.8% 
≥1 66 23.2% 
Lesion side, n (%) 
Right 159 55.8% 
Left 126 44.2% 
Clinical diameter, median IQR 5.0 4.3-5.5 
Tumor location, n (%) 
Polar superior 95 33.4% 
Mesorenal 85 29.8% 
Polar inferior 105 36.8% 
Tumor growth pattern, n (%) 
≥50% Exophytic 180 63.2% 
<50% Exophytic 97 34.0% 
Entirely endophytic 8 2.8% 
Preoperative Hb, median IQR 14.0 13.0-15.0 
Preoperative creatinine, median IQR 1.0 0.8-1.0 
Preoperative eGFR, median IQR 86.0 68.6-100.0 
BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; eGFR, estimated 
glomerular filtration rate; IQR, interquartile rate; SD, standard deviation. 
Table options 
Table 2.  
Comparison of preoperative data between open (OPN), laparoscopic (LPN), and robot-
assisted partial nephrectomy (RAPN) 
Preoperative data 
 
OPN 
(n = 133) 
 
LPN 
(n = 57) 
 
RAPN 
(n = 95) 
 
P* P† P‡ 
Gender, n (%) 
Male 87 65.4% 42 73.7% 42 44.2% 
.26 .01 .38 
Female 46 34.6% 15 26.3% 53 55.8% 
Age, mean SD 62,3 13.8 60.0 13.2 57.3 15.1 0.30 .37 .01 
BMI, median IQR 26,0 
23.2-
29.4 
25.6 
23.5-
28.4 
25.8 
22.5-
27.9 
0.97 .58 .41 
ECOG, n (%) 
0 92 69.2% 43 75.4% 84 88.4% 
.38 .26 .04 
≥1 41 30.8% 14 24.6% 11 11.6% 
Lesion side, n (%) Right 68 51.1% 37 64.9% 54 56.8% .14 .07 .33 
Preoperative data 
 
OPN 
(n = 133) 
 
LPN 
(n = 57) 
 
RAPN 
(n = 95) 
 
P* P† P‡ 
Left 65 48.9% 20 35.1% 41 43.2% 
Clinical diameter, median IQR 5,0 4.5-5.6 5.0 4.3-5.5 5.0 4.1-5.3 0.59 .40 .10 
Tumor location, n 
(%) 
Polar superior 53 39.8% 12 21.1% 30 31.6% 
.03 .46 .30 Mesorenal 33 24.8% 23 40.4% 29 30.5% 
Polar inferior 47 35.3% 22 38.6% 36 37.9% 
Tumor growth 
pattern, n (%) 
≥50% 
Exophytic 
91 68.4% 38 66.7% 51 53.7% 
.57 .12 .24 
<50% 
Exophytic 
36 27.1% 18 31.6% 43 45.3% 
Entirely 
endophytic 
6 4.5% 1 1.8% 1 1.1% 
Hb preoperative, median IQR 14,0 
13.0-
15.0 
14.0 
13.0-
15.0 
14.0 
13.0-
15.0 
0.94 .88 .96 
Creat preoperative, median IQR 0,9 0.7-1.1 1.0 0.9-1.0 1.0 0.9-1.0 0.20 .33 .45 
eGFR preoperative, median IQR 87,0 
66.2-
102.8 
80.0 
69.0-
96.1 
86.0 
69.9-
98.0 
0.13 .16 .99 
Abbreviations as in Table 1. 
* 
OPN vs LPN. 
† 
LPN vs RAPN. 
‡ 
RAPN vs OPN. 
Table options 
A comparison of intra- and postoperative outcomes among open, laparoscopic, and robot-assisted 
approach is reported in Table 3. The minimally invasive approaches, either pure laparoscopic or 
robot assisted, were more frequently exclusive of high-volume centers; indeed, 93% of LPN and 
100% of RAPN were in those centers with high caseload. 
Table 3.  
Comparison of intraoperative and postoperative data between OPN, LPN, and RAPN 
Intra- and postoperative 
data 
OPN 
(n = 133) 
 
LPN 
(n = 57) 
 
RAPN 
(n = 95) 
 
P* P† P‡ 
Intra- and postoperative 
data 
OPN 
(n = 133) 
 
LPN 
(n = 57) 
 
RAPN 
(n = 95) 
 
P* P† P‡ 
High volume center, n (%) 95 71.4% 53 93.0% 95 100.0% .01 .01 <.0001 
Clampless procedures, n 
(%) 
26 19.5% 19 33.3% 13 13.7% .04 .004 .25 
Ischemia time (min), 
median IQR 
16.0 
14.0-
20.0 
24.0 
20.0-
29.0 
18.0 
15.0-
24.0 
<.0001 <.0001 .004 
EBL (cc), median IQR 200 
100-
300 
200 
100-
200 
150 100-200 .46 .04 .01 
Operative time (min), 
median IQR 
135 
110-
170 
129 
110-
150 
155 120-196 .33 .001 .002 
Intraoperative 
complications, n (%) 
8 6.0% 2 3.5% 1 1.1% .48 .29 .05 
Medical postoperative 
complications, n (%) 
17 12.8% 1 1.8% 2 2.1% .02 .88 .04 
Surgical postoperative 
complications, n (%) 
23 17.3% 8 14.0% 8 8.4% .58 .27 .04 
Surgical Clavien 2, n (%) 13 9.8% 4 7.0% 4 4.2% .54 .45 .11 
Surgical Clavien 3, n (%) 7 5.3% 1 1.8% 1 1.1% .27 .71 .09 
Positive surgical margins, n 
(%) 
9 6.8% 1 1.9% 2 2.5% .18 .82 .16 
Trifecta outcome, n (%) 83 62.4% 36 63.2% 66 69.5% .92 .42 .27 
3rd day delta Hb, median 
IQR 
2.0 1.7-3.0 1.0 0.2-3.0 2.4 1.4-3.0 .003 .01 .69 
1st day delta eGFR, median 
IQR 
15.2 
0.0-
28.5 
5.2 
0.0-
16.7 
1.2 0.0-12.6 .02 .22 <.0001 
3rd day delta eGFR, 
median IQR 
9.2 
0.0-
27.6 
7.2 
0.0-
14.0 
1.9 0.0-14.6 .45 .66 .12 
1st month delta eGFR, 
median IQR 
8.7 
0.0-
19.5 
7.3 
0.0-
14.0 
1.6 0.0-13.0 .59 .21 .12 
EBL, estimated blood loss; other abbreviations as in Table 1 and Table 2. 
* 
OPN vs LPN. 
† 
LPN vs RAPN. 
‡ 
RAPN vs OPN. 
Table options 
A clampless procedure was significantly more adopted during LPN (33.3%) than during OPN 
(19.5%; P = .04) and RAPN (13.7%; P = .004). Median (IQR) WIT was significantly shorter during 
OPN (16; 14-20 min) than during LPN (24; 20-29 min) (P < .0001) and RAPN (18; 15-24 min) (P  
= .004). In the minimally invasive group, robotic assistance allowed for significantly lower 
ischemia time in comparison with standard laparoscopy (P < .0001). 
RAPN group showed significantly lower median (IQR) estimated blood loss (EBL) (150; 100-
200 cc) compared with those of OPN group (200; 100-300 cc) (P = .01) and LPN group (200; 100-
200 cc) (P = .04). 
Median (IQR) operative time was significantly higher in RAPN group (155; 120-196 min) with 
respect to OPN (135; 110-170 min) (P = .002) and LPN (129; 110-150) (P  = .001). Intraoperative 
complication rate was lower in RAPN group (1.1%, 1 vascular injury) in comparison with those of 
LPN group (3.5%; 2 vascular injuries; P = .29) and OPN group (6.0%; 3 vascular injuries, 3 pleural 
lesions causing pneumothorax, 1 splenic lesion, and 1 rib fracture; P = .05). 
Medical postoperative complications were significantly higher in OPN group if compared with 
minimally invasive approaches (12.8%, 1.8%, and 2.1%, OPN, LPN, and RAPN, respectively). 
Overall surgical postoperative complications were lower in RAPN group compared with OPN 
(8.4% vs 17.3%, P = .04) and to LPN approach without statistical significance (8.4% vs 14%, P  
= .27). Clavien 2 and Clavien 3 complication rates were lower for RAPN (4.2% and 1.1%) than for 
LPN (7% and 1.8%) and OPN (9.8% and 5.3%), although never reaching statistical significance. 
LPN and RAPN showed a lower rate of positive surgical margins (SM) compared with OPN, 1.9%, 
2.5%, and 6.8% respectively, although not reaching the statistical significance. 
Trifecta was achieved in 62.4%, 63.2%, and 69.5% for OPN, LPN, and RAPN, respectively, with 
no statistical differences among the groups. 
Median (IQR) third postoperative day (POD) hemoglobin drop was significantly lower in LPN (1.0; 
0.2-3.0) with respect to OPN (2.0; 1.7-3.0) (P = .003) and RAPN (2.4; 1.4-3.0) (P  = .01) groups. 
Median (IQR) first POD eGFR drop was higher in OPN (15.2; 0.0-28.5) group with respect to LPN 
group (5.2; 0.0-16.7) (P = .02) and to RAPN group (1.2; 0.0-12.6) (P < .0001). No differences 
among the groups were found when comparing median eGFR drop at the third POD and at 30th 
POD. 
When performing univariate analysis (Table 4), none of the approaches was predictive of Trifecta 
achievement. At multivariable analysis, exophytic tumor growth pattern (odds ratio [OR]: 1.80; 
95% confidence interval [CI]: 1.04-3.12; P = .03), EBL (OR: 0.997; 95% CI: 0.996-0.999; 
P = .001), and the procedure carried out in high-volume centers (OR: 1.96; 95% CI: 0.94-4.07; 
P = .04) were significant predictive factors for Trifecta achievement. 
Table 4.  
Univariate and multivariate analysis for Trifecta achievement 
All Data 
 
Univariate Analysis for 
Trifecta 
 
Multivariable 
Analysis 
 
Not 
Achieved 
 
Achieved 
 
P OR 95% CI P 
Approach, n (%) 
OPN 50 37.6% 83 62.4% .98* 
   
LPN 21 36.8% 36 63.2% .48† 
   
RAPN 29 30.5% 66 69.5% .32‡ 
   
Tumor growth pattern, 
n (%) 
≥50% 
exophytic 
57 31.5% 124 68.5% 
.09 
1.80 1.04-3.12 .03 
<50% 
exophytic 
43 41.3% 61 58.7% – – – 
Tumor location, n (%) 
Polar 
superior 
30 31.6% 65 68.4% .35§ 
   
Mediorenal 33 38.8% 52 61.2% .55|| 
   
Polar inferior 37 35.2% 68 64.8% .65¶ 
   
Clinical diameter, median IQR 5,0 4.3-5.5 5.0 4.3-5.5 .66 
   
EBL, median IQR 200 
120-
350 
150 
100-
250 
<.0001 .997 
0.996-
0.999 
.001 
Clamping pedicle 
performed, n (%) 
No 15 25,9% 43 74,1% 
.09    
Yes 85 37,4% 142 62,6% 
   
Centers, n (%) 
High volume 79 32.5% 164 67.5% 
.03 
1.96 0.94-4.07 .04 
Low volume 21 50.0% 21 50.0% – – – 
CI, confidence interval; other abbreviations as in Table 1 and Table 2. 
* 
OPN vs LPN. 
† 
LPN vs RAPN. 
‡ 
RAPN vs OPN. 
§ 
Polar superior vs mediorenal. 
|| 
Mediorenal vs polar inferior. 
¶ 
Polar inferior vs polar superior. 
Table options 
Discussion 
Current indications for NSS have been expanded to larger tumors; the trigger to a further expansion 
of elective indications has been based on the evidence that PN is comparable with radical 
nephrectomy in oncological outcomes and that renal function is better preserved.
24 and 25
 
Nevertheless, no consensus has been reached yet about the best approach for the treatment of renal 
tumors greater than 4 cm in size. Available literature states that for T1b tumors, PN should be 
performed whenever technically feasible and the open approach is still the gold standard.
1 and 2
 LPN 
is the alternative to OPN in tertiary referral centers, but it is associated with longer WIT and higher 
complication rates.
26
 Initial experiences with RAPN show an overall, recurrence-free, and cancer-
specific survival in T1b tumors comparable with OPN at a 2-year median follow-up
16
 and a trend 
toward a lower WIT respect to LPN.
27
 Indeed, the introduction of robotic system, thanks to the 
advantages of magnified stereoscopic visualization and the articulated instruments, has reduced the 
technical challenges associated with tumor dissection and renorraphy, overcoming the limitations of 
pure laparoscopic approach. 
A few studies focused on the outcomes of RAPN for T1b renal lesions up to date: initial 
experiences underlined a significant higher WIT in T1b compared with T1a renal tumors, 
unsupported by significant difference between two groups in terms of functional outcomes and 
complications.
28 and 29
 None of the published studies is offering a simultaneous comparison among 
the three surgical approaches to T1b lesions. 
Indeed, without a significant difference of preoperative patients and tumor selection between three 
groups (except for a significantly higher rate of mediorenal lesions in LPN compared with OPN and 
a statistically but not clinically significant age difference between RAPN and OPN), Trifecta was 
achieved in 69.5%, 63.2%, and 62.4% of RAPN, LPN, and OPN. The robotic approach was able to 
significantly reduce WIT in comparison with the pure laparoscopic approach and to significantly 
reduce intraoperative and postoperative complications in comparison with the standard open 
approach with a similar positive SM rate in comparison with LPN but lower than OPN although not 
reaching the statistical significance. 
The most possible explanations of reduced complications in robotic approach are attributable to the 
elevated experience of robotic surgeons that were not in their learning phase (also clear by the fact 
that we are analyzing cT1b tumors), and to the benefits of minimally invasive surgery in addition to 
the improved dexterity and vision of robotic system that makes open surgery actions replicable with 
a robotic approach. Furthermore, the reduced PSM rate in LPN and RAPN in comparison with OPN 
is considered as an important pointer that minimally invasive surgery is feasible and safe in the 
treatment of clinical T1b renal tumors. 
Clampless procedures were significantly higher in minimally invasive approaches; this could be 
related to the high-definition view along with the increased abdominal pressure related to the 
pneumoperitoneum that allows a higher control of bleeding during the excision of renal tumor and 
permit the surgeon to perform clampless procedure with greater peace of mind. Robotic approach 
presented a significantly lower rate of clampless compared with LPN, probably for the absence of 
tactile feedback that requires a perfect visual control in a bloodless field. 
Indeed, lowest EBLs were registered with RAPN: this difference, although not clinically relevant, 
was surely due to a precise microdissection of vasculature of renal pedicle and magnified intra-
operative vision that limits bleeding and allows for selective immediate coagulation but also to the 
significantly lower rate of clampless procedures in the RAPN group. 
For the secondary purpose of the study, we performed a univariate and multivariable analyses. The 
three approaches were again compared concerning the rate of Trifecta achievement. 
The trifecta outcome represents a modern standardized tool to evaluate the quality of NSS and to 
more easily compare different approaches with PN. Trifecta is accomplished if the three key 
outcomes of negative cancer margin, minimal renal functional decrease expressed as WIT <25 
minutes and no surgical complications are simultaneously realized.
3, 4 and 5
 
Intra-operative EBL and volume center were the most important factors in predicting the likelihood 
of achieving Trifecta, whereas the surgical approach was not a predictor of a positive trifecta at 
univariate analysis. At multivariable analysis, the same factors together with tumor growth pattern 
were found to be independent predictors of Trifecta achievement. 
The study was not devoid of limitations. Different surgeons were involved and this could 
potentially influence the results. However, this might have increased the external validity of the data 
with respect to a single-center or single-surgeon setting. 
Another limit is the lack of standardized anatomical information in the RECORD 1 database 
generated in 2008 before the publication of the available published nephrometric systems. However, 
the surgical complexity of renal masses was in any case evaluated by the present study according to 
multiple variables, as tumor location and growth pattern. 
Moreover, in centers with minimally invasive expertise, open approach is nowadays reserved to 
imperative indications and very challenging tumors alone, unsuitable for a minimally invasive 
approach, thereby leading to a potential worsening of the outcomes of such an approach for tumors 
over 4 cm. In the present study, the inclusion of centers with different surgical volumes and of 
centers with no minimally invasive experience might have overcome this bias. 
Nevertheless, the very low proportion of cases coming from low volume centers, treated exclusively 
by open PN, shows how the indication to PN for T1b tumors is reserved to high-volume centers and 
still needs to be supported to become a standard vs radical nephrectomy. Conversely, the inclusion 
of tertiary referral centers for LPN might have improved the results of such an approach acting as a 
possible confounder in comparing LPN with the other approaches. 
We recognize that a randomized-controlled trial would be required to draw definitive conclusions 
about the gold standard approach for PN in T1b renal tumors. 
Notwithstanding these limitations, to the best of our knowledge, this paper would represent a 
unique report with the worship of a simultaneous comparison of outcomes of all different 
approaches with NSS for clinically T1b renal tumors. 
Conclusion 
The present study demonstrated that patients with clinically T1b renal tumors suitable for NSS can 
be safely treated by a minimally invasive approach either by LPN or RAPN in high-volume centers. 
If available, robotic approach allows for significantly lower WIT and EBL with higher rate of 
Trifecta achievement compared with LPN. 
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